Stockholm - Delayed Quote SEK

SynAct Pharma AB (SYNACT.ST)

18.26
-0.48
(-2.56%)
At close: May 13 at 5:29:29 PM GMT+2
Currency in SEK All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Gross Profit
0
0
0
0
0
Operating Expense
89,979
89,979
224,496
105,573
76,715
Operating Income
-89,979
-89,979
-224,496
-105,573
-76,715
Net Non Operating Interest Income Expense
-846
-846
220
-247
-105
Pretax Income
-90,825
-90,825
-224,276
-107,066
-76,809
Tax Provision
-8,424
-8,424
-8,466
-7,860
-7,505
Net Income Common Stockholders
-82,401
-82,401
-215,810
-99,205
-69,304
Diluted NI Available to Com Stockholders
-82,401
-82,401
-215,810
-99,205
-69,304
Basic EPS
-2.08
--
-6.64
-3.57
-2.66
Diluted EPS
-2.08
--
-6.64
-3.57
-2.66
Basic Average Shares
39,533
--
32,524
27,836.19
26,083.87
Diluted Average Shares
39,533
--
32,524
27,836.19
26,083.87
Total Operating Income as Reported
-89,980
-89,980
-224,496
-105,705
-76,699
Total Expenses
89,979
89,979
224,496
105,573
76,715
Net Income from Continuing & Discontinued Operation
-82,401
-82,401
-215,810
-99,205
-69,304
Normalized Income
-82,401
-82,401
-215,810
-99,205
-69,304
Interest Income
--
--
593
47
0
Interest Expense
--
--
797
294
105
Net Interest Income
-846
-846
220
-247
-105
EBIT
-89,979
-89,979
-224,496
-106,772
-76,704
EBITDA
-89,979
-89,979
-224,496
-105,754
-76,616
Reconciled Depreciation
--
--
75,336
1,018
88
Net Income from Continuing Operation Net Minority Interest
-82,401
-82,401
-215,810
-99,205
-69,304
Total Unusual Items Excluding Goodwill
--
--
-74,558
0
--
Total Unusual Items
--
--
0
0
--
Normalized EBITDA
-89,979
-89,979
-224,496
-105,754
-76,616
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 7/11/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

P0F.F Egetis Therapeutics AB (publ)
0.3055
-8.40%
 
GENO.ST Genovis AB (publ.)
24.00
-2.83%
 
XSPRAY.ST Xspray Pharma AB (publ)
32.60
-2.54%
 
EGTX.ST Egetis Therapeutics AB (publ)
3.6500
-4.82%
 
KAN.ST Kancera AB (publ)
1.0520
-0.57%
 
ELIC.ST Elicera Therapeutics AB (publ)
5.0000
+5.37%
 
ACE.ST Ascelia Pharma AB (publ)
3.8850
-0.38%
 
DMYD-B.ST Diamyd Medical AB (publ)
9.11
-0.98%
 
SANION.ST Saniona AB (publ)
7.92
-1.98%
 
BIOA-B.ST BioArctic AB (publ)
172.00
-2.38%